Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: JoeinIowa who wrote (3631)	11/10/2003 11:16:11 AM
From: lostmymoney	Read Replies (2) \| Respond to of 23958

Hi all.... NXTI, joe it keeps going up :-) Joe, why the drop with IDSA when earnings were ok? Sopranos own it ya know. LOL

To: JoeinIowa who wrote (3631)	11/10/2003 1:14:10 PM
From: Sergio H	Respond to of 23958

IDSA added @ 4.5 SOTK sold @ .38

To: JoeinIowa who wrote (3631)	11/13/2003 12:29:48 AM
From: LAWRENCE C.	Respond to of 23958

"As impressive as gains were for equities, they paled in comparison with those of precious metals, demonstrating again that the two asset classes can rise in tandem. Gold futures jumped 1.8% to $395 per ounce, their highest close since March 1996. Silver futures surged 5.3% to $5.335 per ounce, their highest level since early September. The Philadelphia Stock Exchange Gold & Silver Index rose 5.6% to a 52-week high of 101.86." quicken.com

To: JoeinIowa who wrote (3631)	11/14/2003 4:15:02 PM
From: JoeinIowa	Read Replies (1) \| Respond to of 23958

ALRG Reports. 11% Revenue growth, 300% earnings growth. Press Release Source: Allergy Research Group, Inc. Allergy Research Group, Inc. Reports Profits For Third Quarter 2003 Friday November 14, 4:00 pm ET HAYWARD, Calif.--(BUSINESS WIRE)--Nov. 14, 2003--Allergy Research Group, Inc. (OTCBB:ALRG - News) announced financial results for the third quarter ending September 30, 2003. ALRG recorded total revenue of $3,326,957 for the quarter, up 11% from 2002. The increase of $326,032 is primarily due to increased sales to distributors and increased demand at retail for current and new products. "Our overall commitment to good health and concern for our customers, coupled with our excellent brand identification, has continued to have a positive effect on sales," said Chief Executive Officer and Chairman, Dr. Stephen A. Levine, Ph.D. Cost of sales increased $82,404 to $1,898,692 for the quarter ended September 30, 2003, compared to $1,816,288 for the quarter ended September 30, 2002. The increase in cost of sales corresponds with the increase in sales. Gross profit margins increased approximately 3.9%, approximating 42.8% for 2003 resulting from the higher margins associated with retail sales. During the quarter ended September 30, 2003, the Company recorded net income of $397,517, as compared to net income of $122,064 for the same period in 2002. The increase is a reflection of the increase in sales at higher profit margins and reduced operating expenses. Interest expense decreased $7,600 for the quarter ended September 30, 2003, as compared to September 30, 2002 as result of the Company paying down its line of credit from $570,064 at December 31, 2001 to zero at September 30, 2003. Complete copies of the company's financial statements, including notes to the financials, can be found on its website at www.nutricology.com.